Skip to main content
Top
Gepubliceerd in:

03-04-2020 | Review

Quality of life in people with epidermolysis bullosa: a systematic review

Auteurs: C. C. G. Togo, A. P. C. Zidorio, V. S. S. Gonçalves, L. Hubbard, K. M. B. de Carvalho, E. S. Dutra

Gepubliceerd in: Quality of Life Research | Uitgave 7/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Individuals with epidermolysis bullosa (EB) present with various clinical manifestations of different severities that affect quality of life (QoL). This systematic review synthesizes the current evidence about the QoL of individuals with EB.

Methods

We included observational studies with people of all age groups, both sexes, and any EB type. Studies with qualitative methodology, chapters of books, meeting proceedings, and abstracts were excluded.

Results

In this study, 12 articles comprising 745 individuals were included. More than half of the articles observed lower QoL in individuals with recessive dystrophic EB (RDEB) or junctional EB (JEB). Three articles indicated that EB affected QoL more in women than in men, and one article identified that children with EB suffered more than adults with the disease. Pain was frequently reported. Seven articles identified difficulty in sports, two identified a need for bathing assistance, and three identified eating difficulties. Additionally, participants reported that family relationships and friendships were affected, and they experienced feelings of anxiety and depression. Some of the instruments used evaluated QoL in general dermatologic conditions, and one was specific to EB.

Conclusion

QoL is more affected in people who have RDEB and JEB. Regarding sex and age, women and children need special care in their monitoring. It is necessary that guidelines on pain management be more disseminated and put into practice. Future studies should use standardized specific instruments to assess the QoL in EB individuals, while considering the particularities of the different age groups.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Fine, J. D., & Mellerio, J. E. (2009). Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I Epithelial associated tissues. Journal of American Academy of Dermatology,61(3), 367–384.CrossRef Fine, J. D., & Mellerio, J. E. (2009). Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I Epithelial associated tissues. Journal of American Academy of Dermatology,61(3), 367–384.CrossRef
2.
go back to reference Intong, L. R., & Murrell, D. F. (2012). Inherited epidermolysis bullosa: New diagnostic criteria and classification. Clinical Dermatology,30(1), 70–77.CrossRef Intong, L. R., & Murrell, D. F. (2012). Inherited epidermolysis bullosa: New diagnostic criteria and classification. Clinical Dermatology,30(1), 70–77.CrossRef
3.
go back to reference Siañez-González, C., Pezoa-Jares, R., & Salas-Alanís, J. C. (2009). Congenital epidermolysis bullosa: A review. Actas Dermo-Sifiliográficas,100(10), 842–856.CrossRef Siañez-González, C., Pezoa-Jares, R., & Salas-Alanís, J. C. (2009). Congenital epidermolysis bullosa: A review. Actas Dermo-Sifiliográficas,100(10), 842–856.CrossRef
4.
go back to reference de Oliveira, Z. N. P., Périgo, A. M., Fukumori, L. M. I., et al. (2010). Imunomapeamento nas epidermólises bolhosas hereditárias. Anais Brasileiros de Dermatologia,85(6), 856–861.CrossRef de Oliveira, Z. N. P., Périgo, A. M., Fukumori, L. M. I., et al. (2010). Imunomapeamento nas epidermólises bolhosas hereditárias. Anais Brasileiros de Dermatologia,85(6), 856–861.CrossRef
5.
go back to reference Haynes, L. (2006). Nutritional support for children with epidermolysis bullosa. British Journal of Nursing,15(20), 1097–1101.CrossRef Haynes, L. (2006). Nutritional support for children with epidermolysis bullosa. British Journal of Nursing,15(20), 1097–1101.CrossRef
6.
go back to reference Fine, J. D., Bruckner-Tuderman, L., Eady, R. A., et al. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. Journal of American Academy of Dermatology,70(6), 1103–1126.CrossRef Fine, J. D., Bruckner-Tuderman, L., Eady, R. A., et al. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. Journal of American Academy of Dermatology,70(6), 1103–1126.CrossRef
7.
go back to reference Zidorio, A. P. C., Dutra, E. S., Leao, D. O. D., et al. (2015). Nutritional aspects of children and adolescents with epidermolysis bullosa: Literature review. Anais Brasileiros de Dermatologia,90(2), 217–223.CrossRef Zidorio, A. P. C., Dutra, E. S., Leao, D. O. D., et al. (2015). Nutritional aspects of children and adolescents with epidermolysis bullosa: Literature review. Anais Brasileiros de Dermatologia,90(2), 217–223.CrossRef
8.
go back to reference Sebaratnam, D. F., McMillan, J. R., Werth, V. P., et al. (2012). Quality of life in patients with bullous dermatoses. Clinical Dermatology,30(1), 103–107.CrossRef Sebaratnam, D. F., McMillan, J. R., Werth, V. P., et al. (2012). Quality of life in patients with bullous dermatoses. Clinical Dermatology,30(1), 103–107.CrossRef
9.
go back to reference Sebaratnam, D. F., Okawa, J., Payne, A., et al. (2015). Reliability of the Autoimmune Bullous Disease Quality of Life (ABQOL) questionnaire in the United States. Quality of Life Research,24(9), 2257–2260.CrossRef Sebaratnam, D. F., Okawa, J., Payne, A., et al. (2015). Reliability of the Autoimmune Bullous Disease Quality of Life (ABQOL) questionnaire in the United States. Quality of Life Research,24(9), 2257–2260.CrossRef
10.
go back to reference The WHOQOL Group. (1995). The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Social Science and Medicine,41(10), 1403–1409.CrossRef The WHOQOL Group. (1995). The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Social Science and Medicine,41(10), 1403–1409.CrossRef
11.
go back to reference Both, H., Essink-Bot, M. L., Busschbach, J., et al. (2007). Critical review of generic and dermatology-specific health-related quality of life instruments. Journal of Investigative Dermatology,127(12), 2726–2739.CrossRef Both, H., Essink-Bot, M. L., Busschbach, J., et al. (2007). Critical review of generic and dermatology-specific health-related quality of life instruments. Journal of Investigative Dermatology,127(12), 2726–2739.CrossRef
12.
go back to reference Frew, J. W., Martin, L. K., Nijsten, T., et al. (2009). Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument. British Journal of Dermatology,161(6), 1323–1330.CrossRef Frew, J. W., Martin, L. K., Nijsten, T., et al. (2009). Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument. British Journal of Dermatology,161(6), 1323–1330.CrossRef
13.
go back to reference Liberati, A., Altman, D. G., Tetzlaff, J., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine,6(7), e1000100.CrossRef Liberati, A., Altman, D. G., Tetzlaff, J., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine,6(7), e1000100.CrossRef
14.
go back to reference McGowan, J., Sampson, M., Salzwedel, D. M., et al. (2016). PRESS peer review of electronic search strategies: 2015 Guideline statement. Journal of Clinical Epidemiology,75, 40–46.CrossRef McGowan, J., Sampson, M., Salzwedel, D. M., et al. (2016). PRESS peer review of electronic search strategies: 2015 Guideline statement. Journal of Clinical Epidemiology,75, 40–46.CrossRef
15.
go back to reference Moola, S., Munn, Z., Tufanaru, C., et al. (2017). The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Case Series. Adelaide: The Joanna Briggs Institute. Moola, S., Munn, Z., Tufanaru, C., et al. (2017). The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Case Series. Adelaide: The Joanna Briggs Institute.
16.
go back to reference Eismann, E. A., Lucky, A. W., & Cornwall, R. (2014). Hand function and quality of life in children with epidermolysis bullosa. Pediatric Dermatology,31(2), 176–182.CrossRef Eismann, E. A., Lucky, A. W., & Cornwall, R. (2014). Hand function and quality of life in children with epidermolysis bullosa. Pediatric Dermatology,31(2), 176–182.CrossRef
17.
go back to reference Yuen, W. Y., Frew, J. W., Veerman, K., et al. (2014). Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Dermato Venereologica,94(4), 442–447.CrossRef Yuen, W. Y., Frew, J. W., Veerman, K., et al. (2014). Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Dermato Venereologica,94(4), 442–447.CrossRef
18.
go back to reference Brun, J., Chiaverini, C., Devos, C., et al. (2017). Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet Journal of Rare Disease,12(1), 1–8.CrossRef Brun, J., Chiaverini, C., Devos, C., et al. (2017). Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet Journal of Rare Disease,12(1), 1–8.CrossRef
19.
go back to reference Cestari, T., Prati, C., Menegon, D. B., et al. (2016). Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese. International Journal of Dermatology,55(2), e94–e99.CrossRef Cestari, T., Prati, C., Menegon, D. B., et al. (2016). Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese. International Journal of Dermatology,55(2), e94–e99.CrossRef
20.
go back to reference Dănescu, S., Sălăvăstru, C., Sendrea, A., et al. (2019). Correlation between disease severity and quality of life in patients with epidermolysis bullosa. Journal of European Academy of Dermatology and Venereology,33(5), e217–e219.CrossRef Dănescu, S., Sălăvăstru, C., Sendrea, A., et al. (2019). Correlation between disease severity and quality of life in patients with epidermolysis bullosa. Journal of European Academy of Dermatology and Venereology,33(5), e217–e219.CrossRef
21.
go back to reference Horn, H. M., & Tidman, M. J. (2002). Quality of life in epidermolysis bullosa. Clinical and Experimental Dermatology,27(8), 707–710.CrossRef Horn, H. M., & Tidman, M. J. (2002). Quality of life in epidermolysis bullosa. Clinical and Experimental Dermatology,27(8), 707–710.CrossRef
22.
go back to reference Jeon, I. K., On, H. R., & Kim, S. C. (2016). Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Annals of Dermatology,28(1), 6–14.CrossRef Jeon, I. K., On, H. R., & Kim, S. C. (2016). Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Annals of Dermatology,28(1), 6–14.CrossRef
23.
go back to reference Kýrová, J., & Bučková, H. (2013). Kvalita života pacientů s epidermolysis bullosa. Czecho-Slovak Dermatology/Cesko-Slovenska Dermatologie, 88(3). Kýrová, J., & Bučková, H. (2013). Kvalita života pacientů s epidermolysis bullosa. Czecho-Slovak Dermatology/Cesko-Slovenska Dermatologie, 88(3).
24.
go back to reference Tabolli, S., Sampogna, F., Di Pietro, C., et al. (2009). Quality of life in patients with epidermolysis bullosa. British Journal of Dermatology,161(4), 869–877.CrossRef Tabolli, S., Sampogna, F., Di Pietro, C., et al. (2009). Quality of life in patients with epidermolysis bullosa. British Journal of Dermatology,161(4), 869–877.CrossRef
25.
go back to reference Margari, F., Lecce, P. A., Santamato, W., et al. (2010). Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. Journal of Clinical Psychology in Medical Settings,17(4), 333–339.CrossRef Margari, F., Lecce, P. A., Santamato, W., et al. (2010). Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. Journal of Clinical Psychology in Medical Settings,17(4), 333–339.CrossRef
26.
go back to reference Reyna, M. J. Á., González, R. M. T., & Salas-Alanís, J. C. (2016). Estrés y calidad de vida en pacientes con epidermólisis ampollar. Derma Cosmética y Quirúrgica,14(2), 112–118. Reyna, M. J. Á., González, R. M. T., & Salas-Alanís, J. C. (2016). Estrés y calidad de vida en pacientes con epidermólisis ampollar. Derma Cosmética y Quirúrgica,14(2), 112–118.
27.
go back to reference Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483. Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
28.
go back to reference Finlay, A. Y., & Khan, G. (1994). Dermatology Life Quality Index (DLQI)—A simple practical measure for routine clinical use. Clinical and Experimental Dermatology,19(3), 210–216.CrossRef Finlay, A. Y., & Khan, G. (1994). Dermatology Life Quality Index (DLQI)—A simple practical measure for routine clinical use. Clinical and Experimental Dermatology,19(3), 210–216.CrossRef
29.
go back to reference Lewis-Jones, M. S., & Finlay, A. Y. (1995). The Children’s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. British Journal of Dermatology,132(6), 942–949.CrossRef Lewis-Jones, M. S., & Finlay, A. Y. (1995). The Children’s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. British Journal of Dermatology,132(6), 942–949.CrossRef
30.
go back to reference Chren, M. M., Lasek, R. J., Quinn, L. M., et al. (1996). Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. Journal of Investigative Dermatology,107(5), 707–713.CrossRef Chren, M. M., Lasek, R. J., Quinn, L. M., et al. (1996). Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. Journal of Investigative Dermatology,107(5), 707–713.CrossRef
31.
go back to reference Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics A,152A(5), 1136–1156.CrossRef Cohen, J. S., & Biesecker, B. B. (2010). Quality of life in rare genetic conditions: A systematic review of the literature. American Journal of Medical Genetics A,152A(5), 1136–1156.CrossRef
32.
go back to reference von der Lippe, C., Diesen, P. S., & Feragen, K. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics and Genomic Medicine,5(6), 758–773.CrossRef von der Lippe, C., Diesen, P. S., & Feragen, K. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics and Genomic Medicine,5(6), 758–773.CrossRef
33.
go back to reference Chernyshov, P. V., Suru, A., Gedeon, I., et al. (2019). Epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire. Journal of European Academy of Dermatology and Venereology,33(3), 612–617.CrossRef Chernyshov, P. V., Suru, A., Gedeon, I., et al. (2019). Epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire. Journal of European Academy of Dermatology and Venereology,33(3), 612–617.CrossRef
34.
go back to reference Schräder, N. H. B., Yuen, W. Y., & Jonkman, M. F. (2018). Pain quality assessment scale for epidermolysis bullosa. Acta Dermato Venereologica,98(3–4), 346–349.CrossRef Schräder, N. H. B., Yuen, W. Y., & Jonkman, M. F. (2018). Pain quality assessment scale for epidermolysis bullosa. Acta Dermato Venereologica,98(3–4), 346–349.CrossRef
35.
go back to reference Goldschneider, K. R., Good, J., Harrop, E., et al. (2014). Pain care for patients with epidermolysis bullosa: Best care practice guidelines. BMC Medicine,12, 178.CrossRef Goldschneider, K. R., Good, J., Harrop, E., et al. (2014). Pain care for patients with epidermolysis bullosa: Best care practice guidelines. BMC Medicine,12, 178.CrossRef
36.
go back to reference Pope, E., Lara-Corrales, I., Mellerio, J., et al. (2012). A consensus approach to wound care in Epidermolysis Bullosa. Journal of American Academy of Dermatology,67(5), 904–917.CrossRef Pope, E., Lara-Corrales, I., Mellerio, J., et al. (2012). A consensus approach to wound care in Epidermolysis Bullosa. Journal of American Academy of Dermatology,67(5), 904–917.CrossRef
37.
go back to reference Denyer, J., & Pillay, E. (2012). Best practice guidelines for skin and wound care in epidermolysis bullosa. In DEBRA: International Consensus. Denyer, J., & Pillay, E. (2012). Best practice guidelines for skin and wound care in epidermolysis bullosa. In DEBRA: International Consensus.
39.
go back to reference Hubbard, L. D., & Mayre-Chilton, K. (2015). Quality of life among adults with epidermolysis bullosa living with a gastrostomy tube since childhood. Quality of Health Research,25(3), 310–319.CrossRef Hubbard, L. D., & Mayre-Chilton, K. (2015). Quality of life among adults with epidermolysis bullosa living with a gastrostomy tube since childhood. Quality of Health Research,25(3), 310–319.CrossRef
40.
go back to reference Zidorio, A. P. C., Dutra, E. S., Castro, L. C. G., et al. (2018). Gastrostomy for epidermolysis bullosa. British Journal of Dermatology,179(1), 42–49.CrossRef Zidorio, A. P. C., Dutra, E. S., Castro, L. C. G., et al. (2018). Gastrostomy for epidermolysis bullosa. British Journal of Dermatology,179(1), 42–49.CrossRef
41.
go back to reference Fine, J. D., & Hintner, H.(2009). In J. D. Fine & H. Hintner (Eds), Life with epidermolysis bullosa (EB) etiology, diagnosis, multidisciplinary care and therapy. Wien: Springer. Fine, J. D., & Hintner, H.(2009). In J. D. Fine & H. Hintner (Eds), Life with epidermolysis bullosa (EB) etiology, diagnosis, multidisciplinary care and therapy. Wien: Springer.
42.
go back to reference Fine, J. D., Johnson, L. B., Weiner, M., et al. (2004). Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clinical and Experimental Dermatology,29(2), 122–127.CrossRef Fine, J. D., Johnson, L. B., Weiner, M., et al. (2004). Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa. Clinical and Experimental Dermatology,29(2), 122–127.CrossRef
43.
go back to reference Dures, E., Morris, M., Gleeson, K., et al. (2011). The psychosocial impact of epidermolysis bullosa. Quality of Health Research,21(6), 771–782.CrossRef Dures, E., Morris, M., Gleeson, K., et al. (2011). The psychosocial impact of epidermolysis bullosa. Quality of Health Research,21(6), 771–782.CrossRef
44.
go back to reference Corbin, J., & Strauss, A. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks, CA: Sage Publications. Corbin, J., & Strauss, A. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks, CA: Sage Publications.
Metagegevens
Titel
Quality of life in people with epidermolysis bullosa: a systematic review
Auteurs
C. C. G. Togo
A. P. C. Zidorio
V. S. S. Gonçalves
L. Hubbard
K. M. B. de Carvalho
E. S. Dutra
Publicatiedatum
03-04-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02495-5